Ehave Expands into the Cannabis Industry -- CFN Media
December 05 2017 - 9:00AM
CFN Media Group ("CannabisFN"), the leading creative agency and
media network dedicated to legal cannabis, announces publication of
an article covering the recent partnership between Ehave Inc.
(OTCQB: EHVVF) and MedReleaf Corp. (TSE: LEAF), one of
Canada’s most prominent licensed producers. The two companies have
joined together to introduce Ehave’s proven and effective patient
management software platform to the medical marijuana industry in
Canada.
There are more than 200,000 registered patients in Health
Canada’s Access to Cannabis for Medical Purposes Regulations
(ACMPR) program. These patients have been purchasing roughly 2,000
kilograms of dried marijuana and the same amount of cannabis oil
each month to treat a wide range of
symptoms. Deloitte analysts believe that the country’s
cannabis industry will continue to grow to upwards of $22.6 billion
over the coming years.
Complex Processes
Most people are familiar with the process of obtaining
traditional medical treatments: You visit a doctor’s office,
receive a consultation, and leave with a prescription. While
medical cannabis is legal in Canada, registering as a patient and
receiving good treatment is difficult.
Patients must first consult with a healthcare professional to
see if they qualify for medical cannabis (assuming that physician
is comfortable prescribing it). Next, the healthcare professional
must submit an authorization form to Health Canada to register the
patient. And finally, the patients must choose a licensed producer
of medical cannabis where they will receive mail order product on a
regular basis.
After the patient is enrolled, many healthcare professionals
find it difficult to follow-up and ensure that the patient is on
the right treatment plan. The medical cannabis industry doesn’t
have the luxury of numerous clinical studies demonstrating the
right dosing and delivery methods, which means that physicians must
rely on their own expertise. The lack of standardization among
licensed producers also means that results may vary.
MedReleaf Agreement
The upshot is that many companies are working on solutions to
make this process a lot easier, including Ehave
Inc. (OTCQB: EHVVF) and MedReleaf Corp. (TSE: LEAF),
one of Canada’s most prominent licensed producers.
Ehave is a provider of patient management, diagnosis, and
treatment technologies for the mental healthcare community. Its
informatics platform facilitates objective, data-driven decision
making while keeping patients informed and engaged throughout their
mental health journey. While its initial focus was on attention
deficit hyperactivity disorder (ADHD) in children, it has recently
moved into the medical cannabis industry.
Ehave launched a robust digital patient intake system
in collaboration with MedReleaf Corp. - a licensed producer of
medical cannabis - back in November. Under the terms of the deal,
Ehave’s technology will be integrated with MedReleaf’s patient and
physician dashboard that is used to establish baseline patient
assessments and track patient-reported symptoms by incorporating a
broad panel of clinically-validated surveys into a single digital
portal.
“We’re pleased to advance our flagship collaboration with
MedReleaf and launch this first product offering for the
investigation of cannabis-based therapies,” said Ehave Inc. CEO
Preteek Dwivedi. “Our core data management technology allows us to
incorporate and centralize any number of validated or novel patient
assessments and surveys into various formats … [providing] a
pathway to clinical validation for emerging treatment
modalities.”
Please follow the link to read the full
article: http://www.cannabisfn.com/ehave-expands-cannabis-industry/
For more information, visit the company’s website
at www.ehave.com.
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media
network dedicated to legal cannabis. We help marijuana businesses
attract investors, customers (B2B, B2C), capital, and media
visibility. Private and public marijuana companies and brands in
the US and Canada rely on CFN Media to grow and succeed.
Learn how to become a CFN Media client company, brand or
entrepreneur: http://www.cannabisfn.com/featuredcompany
Download the CFN Media iOS mobile app to access the world of
cannabis from the palm of your
hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the
Apple App Store logo to receive a download link text on your
iPhone: http://www.cannabisfn.com
Disclaimer:
Except for the historical information presented herein, matters
discussed in this release contain forward-looking statements that
are subject to certain risks and uncertainties that could cause
actual results to differ materially from any future results,
performance or achievements expressed or implied by such
statements. Emerging Growth LLC, which owns CFN Media and
CannabisFN.com, is not registered with any financial or securities
regulatory authority, and does not provide nor claims to provide
investment advice or recommendations to readers of this release.
Emerging Growth LLC may from time to time have a position in the
securities mentioned herein and may increase or decrease such
positions without notice. For making specific investment decisions,
readers should seek their own advice. Emerging Growth LLC may be
compensated for its services in the form of cash-based compensation
or equity securities in the companies it writes about, or a
combination of the two. For full disclosure please
visit: http://www.cannabisfn.com/legal-disclaimer/
CFN Media
Frank Lane
2063697050
flane@cannabisfn.com